Table 2.
Included studies in the meta-analyses
Author | Year of publication | Study design | Age in years mean ± SD (95% CI) | Number of patients (n) |
Gender (F/M) | Follow-up months mean ± SD (95% CI) | Patients available for follow-up (n) | Cartilage assessment | Score | Clinical Outcome | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
With CL/OCL | Without CL/OCL | ||||||||||||||
Mean | SD | n | Mean | SD | n | ||||||||||
Chen et al. [31] | 2019 | Retrospective identification, prospective follow-up | 47 | 36 | 22/14 | 41.7 | 36 | Arthroscopy | AOFAS | 94.76 | 4.78 | 26 | 95.68 | 5.56 | 10 |
Da Cunha et al. [32] | 2018 | Retrospective identification, prospective follow-up | 42.7 | 116 | 50/66 | 20.8 | 70 | Arthroscopy | FAOS | 81.2 | 15 | 55 | 92.1 | 8.2 | 15 |
Zhang et al. [34] | 2018 | Retrospective identification, prospective follow-up | 47.2 | 13 | 4/9 | 14.3 | 13 | Arthroscopy | AOFAS | 85.13 | 6.29 | 8 | 87.6 | 2.88 | 5 |
Boraiah et al. [12] | 2009 | Retrospective identification, prospective follow-up | 51.8 | 153 | 89/64 | 20.9 | 153 | MRI | FAOS | 65.20 | 24.12 | 26 | 66 | 19.32 | 127 |
Aktas et al. [1] | 2008 | Retrospective identification, prospective follow-up | 41.4 | 86 | 38/48 | 33.9 | 86 | Arthroscopy | AOFAS | 95.45 | 6.35 | 24 | 95.68 | 5.56 | 62 |
Yan et al. [33] | 2011 | Retrospective identification, prospective follow-up | 36 | 42 | 17/25 | 12 | 42 | Arthroscopy | AOFAS | 89.58 | 9.76 | 31 | 98.81 | 0.98 | 11 |
44.3 ± 5.5 [95% CI 38.57–50.13] | 446 | 24 ± 11.5 [95% CI 11.79–36.07] | 400 | 170 | 230 |
SD standard deviation, n number of patients, Gender F/M female/male, CI confidence interval